Skip to main content
. 2023 Oct 17;86(6):363–376. doi: 10.1159/000533397

Fig. 8.

Fig. 8.

ROC curve analysis evaluates the sensitivity and specificity of six hub genes as predictive biomarkers for AD and MS diagnosis. CCL2 in AD (a); CD44 in AD (b); GFAP in AD (c); NEFM in AD (d); STXBP1 in AD (e); TCEAL6 in AD (f); CCL2 in MS (g); CD44 in MS (h); GFAP in MS (i); NEFM in MS (j); STXBP1 in MS (k); TCEAL6 in MS (l).